| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10308693 | Seizure | 2005 | 9 Pages |
Abstract
LEV is a well-tolerated new AED that may effectively improve seizure control as an add-on drug in resistant epilepsy in childhood with good tolerability. However, neurologically handicapped children appear at increased risk for reversible neurocognitive side effects and have a poorer treatment response.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Joachim Opp, Ingrid Tuxhorn, Theodor May, Gerhard Kluger, Adelheid Wiemer-Kruel, Gerd Kurlemann, Gunther Gross-Selbeck, Dietz Rating, Ulrich Brandl, Ulrich Bettendorf, Christoph Härtel, Elisabeth Korn-Merker,